This issue of Clinics in Dermatology is dedicated to three skin diseases that attract continuous scientific interest and represent a considerable part of clinical practice: Acne (sometimes referred to as acne vulgaris), rosacea (once called acne rosacea), and hidradenitis suppurativa (formerly called acne inversa). The alternate but similar nomenclature was based on some apparent shared features, including common clinical lesions (papules, nodules, pustules, cysts, pseudocomedones); the pilosebaceous unit being involved as the target organ; the involvement of the face for acne and rosacea; and the fact that hidradenitis may traditionally form part of the follicular occlusion tetrad together with acne conglobata, dissecting cellulitis of the scalp, and pilonidal cyst. Over the years, laboratory and clinical research has pursued refining further distinct pathogenetic, clinical, and therapeutic characteristics for acne, rosacea, and hidradenitis suppurativa. During this pursuit, exciting scientific knowledge has emerged and is highlighted in this issue.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Clinics in Dermatology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Bacterial flora of the normal human skin.J Invest Dermatol. 1950; 15: 305-324
- Propionibacterium levels in patients with and without acne vulgaris.J Invest Dermatol. 1975; 65: 382-384
- Understanding the role of Propionibacterium acnes in acne vulgaris: The critical importance of skin sampling methodologies.Clin Dermatol. 2017; 35: 118-129
- Cutaneous androgen metabolism: Basic research and clinical perspectives.J Invest Dermatol. 2002; 119: 992-1007
- Sex hormones and acne: What’s new?.Clin Dermatol. 2017; 35: 130-137
- Difficult and rare forms of acne.Clin Dermatol. 2017; 35: 138-146
- Objective assessment of acne.Clin Dermatol. 2017; 35: 147-155
- Drug-induced acne.Clin Dermatol. 2017; 35: 156-162
- Priopionibacterium acnes and antimicrobial resistance in acne.Clin Dermatol. 2017; 35: 163-167
- Hormonal therapies for acne.Clin Dermatol. 2017; 35: 168-172
- Topical treatments for acne.Clin Dermatol. 2017; 35: 173-178
- Chemical peels in active acne and acne scars.Clin Dermatol. 2017; 35: 179-182
- Laser and light-based treatments of acne and acne scarring.Clin Dermatol. 2017; 35: 183-189
- Therapeutic approaches to reducing atrophic acne scarring.Clin Dermatol. 2017; 35: 190-194
- Demodex and rosacea revisited.Clin Dermatol. 2016; 35: 201-206
- The ‘red face’: Not always rosacea.Clin Dermatol. 2017; 35: 201-206
- Pharmacologic treatments for rosacea.Clin Dermatol. 2017; 35: 207-212
- Cosmeceuticals for rosacea.Clin Dermatol. 2017; 35: 213-217
- Treatments for hidradenitis suppurativa.Clin Dermatol. 2017; 35: 218-224
- Squamous cell carcinoma arising in long-standing hidradenitis suppurativa: An overlooked facet of the immunocompromised district.Clin Dermatol. 2017; 35: 225-227
© 2016 Elsevier Inc. All rights reserved.